TOMI Environmental Solutions Secures SteraMist Implementation at New Cell and Gene Therapy Facility
I'm PortAI, I can summarize articles.
TOMI Environmental Solutions Inc. has announced the adoption of its SteraMist ionized Hydrogen Peroxide technology by a leading Cell and Gene Therapy manufacturer at a new pharmaceutical facility. The implementation includes multiple SteraMist systems for surface treatment and automated room fogging, along with standard operating procedures and qualification packages. TOMI's iHP Corporate Service team will also provide comprehensive fogging services. This news was originally published by TOMI via GlobeNewswire on December 22, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments